STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma

Cited by (197)

Items 101–197 of 197

1. Trophoblast-macrophage crosstalk on human extravillous under Toxoplasma gondii infection
   Pâmela Mendonça Guirelli, Mariana Bodini Angeloni, Bellisa Freitas Barbosa, A.O. Gomes, Andressa Silva Castro, Priscila Silva Franco, Rafaela José da Silva, J.G. Oliveira, Olindo Assis Martins‐Filho, José Roberto Mineo et al. · 2015 · Placenta
2. MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma Via Dual-Suppressing RhoA/ROCK1 Signaling Pathway
   Jin Long Liu, Jing Li, Jiajia Xu, Fei Xiao, Peng Cui, Zhi Guang Qiao, Xiao Dong Chen, Tao Wei, Xiaoling Zhang · 2018 · Molecular Pharmacology
3. Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-κB/IL-6 signals
   Guangji Wang, Ningjiang Shen, Liang Cheng, Yehan Fang, Hui Huang, Kanghua Li · 2016 · European Journal of Pharmacology
4. Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling
   Sang Hun Lee, Kyeung Bin Lee, Jun Hee Lee, Songhwa Kang, Hwi Gon Kim, Takayuki Asahara, Sang‐Mo Kwon · 2014 · Stem Cells
5. HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells
   Jing Li, Xiuzhong Yan, Jiaxing Tang, Yan Wang, Jian Tang, Wen Wu, Ming Liu · 2019 · Cell Biology and Toxicology
6. FA2H Exhibits Tumor Suppressive Roles on Breast Cancers via Cancer Stemness Control
   Xiaofeng Dai, Shuo Zhang, Hongye Cheng, Dongyan Cai, Xiao Chen, Zhaohui Huang · 2019 · Frontiers in Oncology
7. Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment
   Yong Hong Lei, Chen Junxin, Yong‐Can Huang, Liu Xiaoguang, Bin-Sheng Yu · 2020 · Journal of bone oncology
8. Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
   Jason I. Couto, Misty D. Bear, Jiayuh Lin, Michael Pennel, Samuel Kiyota Kulp, William C. Kisseberth, Cheryl A. London · 2012 · BMC Veterinary Research
9. Phosphoproteomic Profiling Reveals IL6-Mediated Paracrine Signaling within the Ewing Sarcoma Family of Tumors
   Jennifer Lynn Anderson, Bjoern Titz, Ryan Akiyama, Evangelia Komisopoulou, Ann Park, William D. Tap, Thomas G. Graeber, Christopher T. Denny · 2014 · Molecular Cancer Research
10. Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies
    Jiannan Li, Wěi Li, Lanqing Cao, Ning Liu, Kai Zhang · 2020 · World Journal of Gastrointestinal Oncology
11. An integrative analysis of DNA methylation in osteosarcoma
    Jie Xu, Deng Li, Zhiqing Cai, Yingbin Zhang, Yulin Huang, Baohua Su, Ruofan Ma · 2017 · Journal of bone oncology
12. Association of interleukin 16 gene polymorphisms and plasma IL16 level with osteosarcoma risk
    Yujin Tang, Junli Wang, Kegong Xie, Changgong Lan · 2016 · Scientific Reports
13. The antiviral cytokine interferon‐gamma restricts neural stem/progenitor cell proliferation through activation of STAT1 and modulation of retinoblastoma protein phosphorylation
    Apurva Kulkarni, Taylor J. Scully, Lauren A. O’Donnell · 2016 · Journal of Neuroscience Research
14. IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells
    Yanqiang Chen, Jianzhen Liu, Pei Lv, Jiangyan Gao, Mingzheng Wang, Yongjun Wang · 2017 · Cell Adhesion & Migration
15. Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial–Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells
    Junjie Wang, Weilin Yang, Tao Wang, Xiaoyong Chen, Jiancheng Wang, Xiaoran Zhang, Chuang Cai, Beilong Zhong, Jiabin Wu, Zhenguang Chen et al. · 2018 · Scientific Reports
16. TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production
    Xiuguo Han, Huimin Mo, Xuqiang Liu, Yan Li, Lin Du, Han Qiao, Qiming Fan, Jie Zhao, Shu-hong Zhang, Tingting Tang · 2018 · Frontiers in Genetics
17. Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells
    Mohammed L. Ibrahim, Chunwan Lu, John David Klement, Priscilla S. Redd, Dafeng Yang, Alyssa D. Smith, Kebin Liu · 2020 · Cancer Immunology Immunotherapy
18. Stat3 Upregulates Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4 Expression in Osteosarcoma Cells
    Jia Liu, Wei Wei, Changan Guo, Ning Han, Jianfeng Pan, Teng Fei, Zuoqin Yan · 2013 · BioMed Research International · Retracted
19. Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms
    Yinglong Zhang, Qiong Ma, Tao Liu, Ke Shi, Kuo Jiang, Yanhua Wen, Baoan Ma, Yong Zhou, Qingyu Fan, Xiuchun Qiu · 2013 · Journal of Cancer Research and Clinical Oncology
20. Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cells
    Radwa Ayman Salah, M. Nasr, Azza M. El-Derby, M. Abd Elkodous, Rania Hassan Mohamed, Nada Magdy El-Ekiaby, Aya Osama, Shimaa E. Elshenawy, Merna Hatem Mohamed Hamad, Sameh Magdeldin et al. · 2021 · Life Sciences
21. Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?
    Viviana De Martino, Michela Rossi, Giulia Battafarano, Jessica Pepe, Salvatore Minisola, Andrea Del Fattore · 2021 · International Journal of Molecular Sciences
22. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells
    Shuwei Zhang, Yi Wang, Shuzhen Chen, Jingfeng Li · 2018 · Biomedicine & Pharmacotherapy
23. Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients
    Baron, Max, Drohat, Philip, Crawford, Brooke, Hornicek, Francis J., Best, Thomas M., Kouroupis, Dimitrios · 2023 · Bioengineering
24. Chorioallantoic Membrane Assay at the Cross-Roads of Adipose-Tissue-Derived Stem Cell Research
    Dmytro Oliinyk, Andreas Eigenberger, Oliver Felthaus, Silke Haerteis, Lukas Prantl · 2023 · Cells
25. Signal transducers and activators of transcription 3 function in lung cancer
    Yue-Chuan Li, Chun-Jie Li, Dongrui Zhang, Jianhui Pan · 2013 · Journal of Cancer Research and Therapeutics
26. Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapy
    Aurélie Dutour, Michela Pasello, Luke Farrow, Mahetab H. Amer, Natacha Entz‐Werlé, Michaela Nathrath, Katia Scotlandi, Sibylle Mittnacht, Anne Gomez‐Brouchet · 2025 · Cancer and Metastasis Reviews
27. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance
    Ali Amin Asnafi, Masumeh Maleki Behzad, Majid Ghanavat, Mohammad Shahjahani, Najmaldin Saki · 2018 · Experimental and Molecular Pathology
28. Gossypetin Is a Novel Modulator of Inflammatory Cytokine Production and a Suppressor of Osteosarcoma Cell Growth
    Carina Proença, Ana Teresa Rufino, Isabela Santos, Hélio M. T. Albuquerque, Artur M. S. Silva, Eduarda G. R. Fernandes, José Miguel P. Ferreira de Oliveira · 2023 · Antioxidants
29. Heat Effect Induces Production of Inflammatory Cytokines Through Heat Shock Protein 90 Pathway in Cornea Cells
    Ming‐Ju Tsai, Ya‐Ling Hsu, Kwou‐Yeung Wu, Rei‐Cheng Yang, Yi‐Jen Chen, Hsin‐Su Yu, Po‐Lin Kuo · 2013 · Current Eye Research
30. The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy
    Muhammad Tufail, Kunxiang Gong, Bushra Ijaz, Harsh H. Patel, Weng‐Onn Lui, Xiumei Wang, Jie Li · 2026 · Drug Resistance Updates
31. Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
    Banu İskender, Kenan İzgi, Çağrı Şakalar, Halit Canatan · 2015 · Tumor Biology
32. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation
    Yu Guo, Fei Wu, Ersong Wang · 2016 · Cellular Physiology and Biochemistry
33. Correlation Between Immunoinflammatory Measures and Periostin Expression in Esophageal Squamous Cell Carcinoma: A Single-Center, Retrospective Cohort Study
    Yusuke Ishibashi, Hironori Tsujimoto, Takahiro Einama, Satsuki Mochizuki, Keita Kouzu, Shinsuke Nomura, Nozomi Ito, Manabu Harada, Hidekazu Sugasawa, Eiji Shinto et al. · 2020 · Annals of Surgical Oncology
34. Osteosarcoma through the Lens of Bone Development, Signaling, and Microenvironment
    Elizabeth P. Young, Amanda E. Marinoff, Eunice López-Fuentes, Alejandro Sweet-Cordero · 2024 · Cold Spring Harbor Perspectives in Medicine
35. Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma
    Toshinori Ando, Yasusei Kudo, Shinji Iizuka, Takaaki Tsunematsu, Hanako Umehara, Madhu Shrestha, Toshihiro Matsuo, Tadahiko Kubo, Shouji Shimose, Koji Arihiro et al. · 2017 · Scientific Reports
36. Flavonoid Compounds Contained in Epimedii Herba Inhibit Tumor Progression by Suppressing STAT3 Activation in the Tumor Microenvironment
    Cheng Pan, Yukio Fujiwara, Hasita Horlad, Daisuke Shiraishi, Toyohisa Iriki, Jyunko Tsuboki, Tsuyoshi Ikeda, Yoshihiro Komohara · 2020 · Frontiers in Pharmacology
37. Metastasis suppressor Nm23-H1 inhibits STAT3 signaling via a negative feedback mechanism
    Lei Gong, Zhihao Wu, Lili Guo, Lin Li, Rongzhi Zhao, Daxing Zhu, Qinghua Zhou · 2013 · Biochemical and Biophysical Research Communications
38. Molecular mechanisms underlying the inhibitory effects of bovine lactoferrin on osteosarcoma
    Chanbora Chea, Sivmeng Haing, Mutsumi Miyauchi, Madhu Shrestha, Hiromichi Imanaka, Takashi Takata · 2018 · Biochemical and Biophysical Research Communications
39. MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen
    Yuan Yuan, Yonggang Wang, Zimei Liu, Yong Sun, Yang Yao, Wenxi Yu, Zan Shen · 2019 · International Journal of Oncology
40. Irisin’s Dual Role in Malignant Tumors and Its Potential as a Biomarker and Therapeutic Target
    Liqun Mo, Xu Zeng, Yu Liu, Jin Zhang, Li Liu, Yingying Zhang, Yiping Bai · 2025 · Drug Design Development and Therapy
41. LncRNA DLEU2 promotes tumour growth by sponging miR‐337‐3p in human osteosarcoma
    Wei Liu, Pengcheng Liu, Ke Ma, Yuanyi Wang, Qing‐bao Chi, Ming Yan · 2020 · Cell Biochemistry and Function
42. Surface Markers and Chemokines/Cytokines of Tumor-Associated Macrophages in Osteosarcoma and Other Carcinoma Microenviornments—Contradictions and Comparisons
    Rikito Tatsuno, Yoshihiro Komohara, C. Pan, T. Kawasaki, Atsushi Enomoto, Takahiro Jubashi, Hiroyuki Kono, Masanori Wako, Tomoyuki Ashizawa, Hirotaka Haro et al. · 2024 · Cancers
43. Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2.
    Lin Du, Qiming Fan, Bing Tu, Wei Yan, Tingting Tang · 2014 · PubMed Central
44. An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma
    Mojdeh Safari · 2014 · World Journal of Stem Cells
45. To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
    Chunfeng Xu, Mingjie Wang, Behrouz Zandieh‐Doulabi, Wei Yan Sun, Lingfei Wei, Yuelian Liu · 2021 · Frontiers in Cell and Developmental Biology
46. Human Bone Xenografts: from Preclinical Testing for Regenerative Medicine to Modeling of Diseases
    Mark Seow Khoon Chong, Chaolemeng Bao, King Pan Ng, Jing Lim, Jerry Kok Yen Chan · 2016 · Current Molecular Biology Reports
47. The effects of STAT3 acetylation on the transcriptional activity and tumorigenesis
    Huaying Yan, Linmei Tang, Yuan Zhu, Yaodan Zhang · 2025 · Biochemical Pharmacology
48. Modeling the effects of radiation on the bone tumor microenvironment: opportunities for exploring combination therapies in microphysiologic systems
    Kailey N. Jackett, Devin L. DaPonte, Pranav Soman, Jason A. Horton · 2025 · Cellular & Molecular Biology Letters
49. Mesenchymal stroma drives axonogenesis and nerve-induced aggressiveness in osteosarcoma
    Gemma Di Pompo, Thimios A. Mitsiadis, Pierfrancesco Pagella, Alessandro Pasquarelli, Giuliano Bettini, Silvia Sabattini, Alberto Righi, Sofia Avnet, Nicola Baldini · 2025 · Journal of Experimental & Clinical Cancer Research
50. Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
    Ya-Ting Yang, Vilma Yuzbasiyan‐Gurkan · 2022 · International Journal of Molecular Sciences
51. Emerging cytokine networks in osteosarcoma
    Luís Carlos Lopes‐Júnior, Denise Sayuri Calheiros da Silveira, Anderson Vulczak, Jéssica Cristina dos Santos, Luciana Chain Veronez, Andressa Fisch, Milena Flória‐Santos, Regina Aparecida Garcia de Lima, Gabriela Pereira da Silva · 2016
52. EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway In Vitro
    Kuo-Lung Tung, Yen-Ting Wu, Cheng Liu, Sheng‐Chieh Lin, Chin‐Han Wu, Shih-Yi Wu, Yao Chang, Yu-Yan Lan · 2020 · Anticancer Research
53. Microenvironment Signals and Mechanisms in the Regulation of Osteosarcoma
    Yu Zhang, Qing Mai, Xiaowen Zhang, Chunyuan Xie, Yan Zhang · 2017 · InTech eBooks
54. Microarray Based Functional Analysis of Myricetin and Proteomic Study on Its Anti-Inflammatory Property
    Tao Li, Jihe Zhu, Fangming Deng, Weiguo Wu, Zhibing Zheng, Chenghao Lv, Yong Li, Wei Xiang, Xiangyang Lu, Si Qin · 2019 · BioMed Research International
55. Cancer-associated fibroblasts in osteosarcoma: key players in immune escape and targeted therapy
    Junjie Fan, Yujie Jin, Feng Lv, Weidong Wu, Li Sun, Churong Wang · 2025 · Frontiers in Immunology
56. Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
    Jiuhui Xu, Chenglong Chen, Kunkun Sun, Qianyu Shi, Boyang Wang, Yi Huang, Tingting Ren, Xiaodong Tang · 2023 · Frontiers in Oncology
57. STAT Activation in Malignancies: Roles in Tumor Progression and in the Generation of Antineoplastic Effects of IFNs
    Ben X. Wang, Leonidas C. Platanias, Eleanor N. Fish · 2013 · Journal of Interferon & Cytokine Research
58. Current Status of Proteomics in Ewing's Sarcoma
    Tadashi Kondo · 2018 · PROTEOMICS - CLINICAL APPLICATIONS
59. Pathobiology and Molecular Pathways Implicated in Osteosarcoma Lung Metastasis: A Scoping Review
    Ala Bashir, Ayden Ismail, Avenie Mavadia, Aruni Ghose, Saak Victor Ovsepian, Stergios Boussios · 2025 · Technology in Cancer Research & Treatment
60. Knockdown of astrocyte elevated gene-1 inhibits growth through suppression of IL-6 secretion in HepG2 human hepatoma cells
    Huan Deng, Zhenzhen Zhou, WEI TU, Yujia Xia, Huanjun Huang, Dean Tian · 2013 · Oncology Letters
61. Androgen attenuates antitumor effects of gastric cancer cells by bone marrow mesenchymal stem cells via restricting the JNK signaling activation
    Linsong Mu, Wu Sui, Lin Yang, Wentao Yu, Hailong Su, Xiang Yu, Chengkun Qin · 2019 · Translational Cancer Research
62. Retracted Article: Exosomal miR-25-3p derived from hypoxia tumor mediates IL-6 secretion and stimulates cell viability and migration in breast cancer
    Zhengmin Li, Fang He, Zhan-Jia Yang, Xueming Cao, Shuyang Dai, Jie Zou, Poshi Xu, Zhou Zhou · 2019 · RSC Advances · Retracted
63. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b+ myeloid cells to the lungs and facilitates B16-F10 melanoma colonization
    Lucas Eduardo Botelho de Souza, Danilo Cândido de Almeida, Juliana Navarro Ueda Yaochite, Dimas Tadeu Covas, Aparecida Maria Fontes · 2015 · Experimental Cell Research
64. Tamarix honey phenolics attenuate cisplatin-induced kidney toxicity by inhibition of inflammation mediated IL-6/STAT3/TNF-α and oxidative stress-dependent Nrf2/caspase-3 apoptotic signaling pathways
    Hanan Y. Aati, Sultan Y. Aati, Hebatallah S. Bahr, Asmaa Ramadan Abdel-Sattar, Marwa Ahmed Embaby, Ahmed M. Reda, Usama Ramadan Abdelmohsen, Gerhard Bringmann, Hossam M. Hassan, Mostafa Assem Darwish · 2025 · Frontiers in Pharmacology
65. Osteogenesis in the presence of chemotherapy: A biomimetic approach
    Ava Brozovich, Stefania Lenna, Francesca Paradiso, Stefano Serpelloni, Patrick C. McCulloch, Bradley Kenneth Weiner, Jason Todd Yustein, Francesca Taraballi · 2022 · Journal of Tissue Engineering
66. Targeting the osteosarcoma immune microenvironment for improved immunotherapy and translational applications
    Jinlin Cai, Shijie Qiu, Biao Sun, Jianbin Ge, Zhe Yu, Chao Wang · 2025 · Discover Oncology
67. The heterogeneity and drug resistance of malignant cells and intercellular communication of microenvironment in osteosarcoma: Based on single‐cell analysis
    Haonan Ma, Xiaoyu Wang, Jiayi Zhao, Jiayi Wang, Qian Li, Jinrong Liang, Xiaomin Ding, Yawen Zhang, Yan Zhou, Haiyan Hu · 2023 · Clinical and Translational Discovery
68. Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models
    Jinglei Miao, Shijie Chen, Hongqing Cao, Zhiyu Ding, Yuezhan Li, Weiguo Wang, Keshav Nundlall, Youwen Deng, Jinsong Li · 2024 · Molecular Carcinogenesis
69. Osteosarcoma: A review with emphasis on pathogenesis and chemoresistance
    Steven J. Kuerbitz, Matthew B. Henderson · 2020 · Medical Research Archives
70. Deregulation of osteoblast differentiation in primary bone cancers
    Pierre J. Marie, Olivia Fromigué, Dominique Modrowski · 2014 · Elsevier eBooks
71. Correction to: Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition
    Tao Zhang, Suoyuan Li, Jingjie Li, Fei Yin, Yingqi Hua, Zhouying Wang, Binhui Lin, Hongsheng Wang, Dongqing Zou, Zifei Zhou et al. · 2018 · Cell Death and Disease
72. Evaluation of Two Novel Therapeutics Against Human and Canine Osteosarcoma
    Heather M. Wilson-Robles, Tasha M. Miller, Chao Sima A, Jianping Hua A, Milana Cypert, Michael L. Bittner · 2020 · Research Square
73. TNF-α orchestrates ADAM metallopeptidase with thrombospondin type 1 motif 2 upregulation and extracellular matrix remodeling through multimodal signaling in osteosarcoma cells
    Ehed Muhammed Aymaz, Meltem Alper, Yasemin KALFA, FERAY TURA KOCKAR · 2026 · Molecular Biology Reports
74. Effect of miR-98/IL-6/STAT3 on Autophagy and Apoptosis of Cardiac Stem Cells Under Hypoxic Conditions In vitro
    Xueyuan Li, Yang Zhang, Guangwei Zhang · 2024 · Current Stem Cell Research & Therapy
75. Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity
    Mariana Medeiros, Sophia Guenka, David Bastos, Karla Laissa Oliveira, María Sol Brassesco · 2024 · Pharmaceuticals
76. Treatment of Children with Osteosarcoma
    Maxim Yu. Rykov, Сенжапова Эльмира Рифатовна · 2019 · IntechOpen eBooks
77. Connections between Early-Life Neuroinflammation, Neural Stem Cells and Progenitors and Origins of Neuropsychiatric Disorders
    Ekta Kumari, Fernando Janczur Velloso, Steven W. Levison · 2019 · OBM Neurobiology
78. Cancer stem cells and clonal evolution in bone sarcomas
    René Rodrı́guez, Jiřı́ Hatina, Stefano Gambera, Sofía T. Menéndez, Javier Garcı́a-Castro · 2021 · Elsevier eBooks
79. Biomaterial Screening Identifies Enhanced Osteogenic and Angiogenic Potential of Mn-Doped Calcium Phosphate Coatings
    Maria José Eischen-Loges, Zeinab Niloofar Tahmasebi Birgani, Yousra Alaoui Selsouli, Virginie Joris, Lars Eijssen, Nadia J. T. Roumans, Hoon Suk Rho, Martijn van Griensven, Vanessa L.S. LaPointe, Pamela Habibović · 2026 · ACS Biomaterials Science & Engineering
80. Decoding CTCs in osteosarcoma: the molecular journey from initial tumor to metastasis
    Alessandro Di Gangi, Mariangela Morelli, Edoardo Ipponi, Fabrizio Catena, Luca Coccoli, Raffaele Gaeta, Paolo Aretini, Michele Menicagli, Alessandro Franchi, Gaia Palmini et al. · 2026 · Scientific Reports
81. Osteosarcoma as a communication-driven disease: redefining tumor–bone signaling networks as therapeutic targets
    Gabriele Ricciardi, Vincenzo Fiorentino, Pietro Tralongo, Maria Lentini, Ludovica Rita Pepe, Valeria Zuccalà, Mariagiovanna Ballato, Giuseppe Giuffrè, Antonio Ieni, Biagio Zampogna et al. · 2026 · Frontiers in Oncology
82. Comprehensive analysis of immune implication and prognostic value of DHX33 in sarcoma
    Xinan Zhang, Yiming Shao, Yaqi Zhou, Zhi Hong Zhu, Xiaohu Wang · 2023 · Medicine
83. Impact of anti-viral immunity on neural stem/progenitor cell activity and implications for CNS development
    Apurva Kulkarni · 2017
84. Influência de Toxoplasma gondii (cepas RH e ME49) na modulação da apoptose de células trofoblásticas (Linhagem BeWo)
    Mariana Bodini Angeloni · 2013
85. Osteosarcoma – on the way to personalized therapy. Part II: personalized therapy of the future
    Maksim Yu. Rykov, Сенжапова Эльмира Рифатовна · 2019 · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
86. A influência da infecção por Toxoplasma gondii na comunicação entre células trofoblásticas extravilosas humanas e macrófagos
    Pâmela Mendonça Guirelli · 2014
87. Isolation, purification and partial characterisation of cancer procoagulant from placental amnion-chorion membranes and its role in angiogenesis inflammation and metastasis
    Jason Krause · 2014 · Nelson Mandela University Research Repository
88. Growth factors, cytokines, and pediatric malignant primary bones tumors
    Bénédicte Brounais-Le Royer, Frédéric Lézot · 2021 · Elsevier eBooks
89. Contribution à la conception d'une prothèse de main communicante et "intelligente"
    Mirna Atieh · 2008
90. Treatment of children with osteosarcoma
    Сенжапова Эльмира Рифатовна, Maksim Yu. Rykov · 2019 · Yakut Medical Journal
91. Plasma proteins and osteosarcoma: Mendelian randomization analysis and targeted therapeutic discovery
    Liang Zhao, Juncheng Shen, Xi Zheng, Qiao Yuan, Junwu Ye · 2025 · Medicine
92. Additional file 2 of Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications
    Zhuang, Wei-Zhan, Lin, Yi-Heng, Su, Long-Jyun, Wu, Meng-Shiue, Jeng, Han-Yin, Huan‐Cheng Chang, Huang, Yen-Hua, Ling, Thai-Yen · 2021 · Figshare
93. Additional file 1 of Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications
    Zhuang, Wei-Zhan, Lin, Yi-Heng, Su, Long-Jyun, Wu, Meng-Shiue, Jeng, Han-Yin, Huan‐Cheng Chang, Huang, Yen-Hua, Ling, Thai-Yen · 2021 · Figshare
94. Current Trends in Mesenchymal Stem Cell Research for Osteosarcoma from 2005 to 2024: A Bibliometric Study
    Yinyao Gou, Likun Wei, Rensong Li, Zhigang Xiao, Lanqing Fu, Xin Zhao, Lianshan Qi, Hao Liu · 2026 · Journal of Orthopaedics
95. The Osteosarcoma Tumor Microenvironment: From Cellular Interactions to Advanced Preclinical Models
    Giuseppe Di Feo, Alessandra Di Paola, Oriana Di Domenico, Lucia Argenziano, Elvira Pota, Daniela Di Pinto, Martina Di Martino, Maria Maddalena Marrapodi, Francesca Rossi · 2026 · Cancers
96. Protein degraders targeting JAK/STAT3 signaling pathway are emerging therapeutic modalities for human cancers
    Xinyu Feng, Nanjing Li, Xiaorong Chen, Xinyue Cao, Jingling Dai, Shaoquan Xiong, Zhu Yuan · 2026 · Biochemical Pharmacology
97. BindingDB Entry 50017859: Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis.
    BindingDB · 2023 · UC San Diego